FDA Investigator Dr. Jason R Caballero

Dr. Jason R Caballero has inspections in 9 countries as of 26 Sep 2023. Dr. Jason R Caballero has collaborated with a combinined 4096 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
98
Last Inspection Date:
26 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100006713
Country:
United States of America, India, Germany, Italy, Colombia, France, Japan, Mexico
Co-Investigator(s):
Adam C Hipko, Adam R Cooke, Ademola O Daramola, Adree N Anderson, Akbar J Zaidi, Alan L Truong, Alan P Kurtzberg, Albert F Peacock, PhD, Alesya V Oleynik, Alice S Tsao, Ana P Pineda Zavaleta, Andrea A Branche, Andrew A Hoopes, Angela E Glenn, Anh M Lac, Anitha P Govada, Anya D Lockett Evans, Ariel Cruz Figueroa, Arsen Karapetyan, Azza Talaat, Babatunde Ojo, Blondell W Johnson, Bonita S Chester, Brandi E Williams, Brent T Hall, Brett D Weed, Brett Weed, Brittany D Terhar, Bruce E Taylor, Camerson E Moore, Candace S Tucker, Carl J Montgomery, Cassandra L Abellard, Chad W Rice, Chaoying C Ma, Charles B Steinmiller, Charles D Brown, Charles I Ann, Charles M Edwards, Cheryl A Clausen, Christopher B May, Christopher D Snyder, Christopher J Smith, Christopher R Czajka, Chunsheng Cai, PhD, Closek, Cody J Alley, Collins M Mason, Connie Hannon Rabel, Connie L Hannon Rabel, Cynthia J Lee, MS, Danial S Hutchison, Daniel J Lahar, Daniel L Obrzut, Darla J Christopher, Darrah, David J Eide, David J Gomes, David M Beltran, Demitria J Xiradakis, Dennis Cantellops Paite, Derek S Dealy, Dr. Carmelo Rosa, Edward D Edmiston, Edward Lukeman, Elisa M Fleming, Ellen J Tave, Emilio O Escobar, Eric T Huebler, Erika V Butler, Frans E Mercado, George J Flynn, Gideon N Esuzor, Gilbert Valdez, RS, Grant, H Ljamilla Selby, Hala L Selby, Heath W Cartwright, Hung V Le, Iris C Macinnes, Ivis Lnegron Torres, Jamie M Du, Janesa A Licorish, Jason F Chancey, Javier O Vega, Jawaid Hamid, Jeffery A Hangartner, Jeffrey D Meng, Jenny Agila Sefen, Joanne Heim, Jocelyn C Turner, Jodi M Gatica, Joel D Martinez, Johann M Fitch, John A Iwen, John T Chapman, Johnsont, Jose Alopez Rubet, Jose E Melendez, DDC, Jose M Cayuela, Jose Martinez, Jr, Jose R Hernandez, Joselin P Baray Alvarado, Juan Rjimenez Garcia, June P Page, Justin A Boyd, Karen C Daugherty, Karen L Kosar, Karen M Montgomery (KMM), Kari M Johansen, Kari M Laynor, Katherine E Jacobitz, Katherine M Taylor, Kathleen B Swat, Kathleen J Close, Kathleen M Bradley, Kellia N Hicks, Kelly D Sheppard, Kenitra D Hewitt, Kevin T Nguyen, Khalid M Khan, Kim Lthomas Cruse, Kristi B Panzer, Lata C Mathew, PhD, Latorie S Jones, Latrecia D Stubbs, Leighton K Ngai, Linda L Ng, Linda Thai, Lindsay P Williams, Lindsey M Schwierjohann, Linhart, Lisa M Bellows, Lisa M Pence, Lisa R Jennings, Lisa R Whitt, Lori A Gioia, Louis S Chen, Lourdes R Genera, Luis M Burgos Medero, Maira P Brading, Marcus A Ray, Margaret M Annes, Maria Estrella, Marie F Morin, Marissa S Steinhagen, Martinez, Matthew B Casale, Matthew R Maddox, Maya M Davis, Meisha Waters, Michele Perry Williams, Miguel A Martinez, Mpris Inspector, Mra Mcculloughj, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Natalie J Ayoub, Nebil A Oumer, Nerizza B Guerin, Ngoc B Kelsch, Nicholas A Violand, Niketa Patel, Noreen Muniz, Paige E Shelborne, Parul M Patel, Patrice S Hall, Patricia M Jacobs, Patrick C Klotzbuecher, Patrick D Stone, MS, Patty P Kaewussdangkul, Paula J Perry, Pauline N Logan, Penny H Mccarver, Philip M Steele, PhD, Pitman, Rachael A Moliver, Rafael Nevarez Nieves, Raymond T Oji, Reba A Gates, Rebecca C O Bryan, Rian L Pope, Robert C Steyert, Robert D Tollefsen, Robert J Martin, Robert T Lorenz, Rodney L Tinzie, Rose Ashley, Rose M Ashley, Rumany C Penn, PharmD, Ryan S Martin, Samantha J Bradley, Samuel K Gibbons, Jr, Sandra A Hughes, Sangeeta M Khurana, PhD, Santos E Camara, Scot M Stodola, Scott A Jepson, Scott T Ballard, Seneca D Toms, Sha'tina R Alridge, Shalonda C Clifford, Shanna N Purdy, Shaun M Olson, Shawn B Johnson, Shelby N Marler, Sina Shojaee, Sondra L Phillips, Sonia R Peterson, Sonya M Edmonds, State Agency, Stephen D Brown, Steven D Kehoe, Steven M Weinman, Susan F Laska, MS, Suzanne N Vallez, Teresa I Navas, Theresa Kirkham (NMI), Thomas J Arista, Thuy T Nguyen, LCDR, Timothy H Vo, Timothy T Kapsala, Torrance J Slayton, Tracey L Harris, Tracy R Ball, Tricia S Martinez, Tristian E Strait, Uttaniti Limchumroon (Tom), Vioela J Caze, Viviana Matta, Vlada Matusovsky, Walsworth, Wei Huaemily Wu, William C Corley, Xiomara Copeland, Youmin Wang, Youngjd

Dr. Jason R Caballero's Documents

Publish Date Document Type Title
February, 2019 FDA 483 Industria Farmaceutica Andromaco S.A. de C.V. - Form 483, 2019-02-01
December, 2019 FDA 483 BEL STAR S A - Form 483, 2019-12-13
May, 2015 FDA 483 Abrams Royal Pharmacy II, LLC - Form 483, 2015-05-11
August, 2019 FDA 483 Stonegate Pharmacy LP - Form 483, 2019-08-09
March, 2018 FDA 483 MICROBIOPHARM JAPAN CO., LTD. - Form 483, 2018-03-16
August, 2015 FDA 483 Option Care - Form 483, 2015-08-06
June, 2019 FDA 483 Custom Compounding Center - Form 483, 2019-06-04
January, 2017 FDA 483 Response South Texas Botanicals - Form 483R, 2017-03-17
December, 2019 FDA 483 EECORGANICOS DE COLOMBIA S A S - Form 483, 2019-12-06
October, 2019 FDA 483 Sato Pharmaceutical Co., Ltd. - Form 483, 2019-10-25
August, 2018 FDA 483 Lusochimica SpA - Form 483, 2018-08-03
November, 2018 FDA 483 Downing Labs, LLC - Form 483, 2018-11-19
December, 2015 FDA 483 Elkhart Pharmacy - Form 483, 2015-12-21
August, 2016 EIR DPT Laboratories, Ltd. - EIR, 2016-08-29
March, 2017 FDA 483 American Specialty Pharmacy - Form 483, 2017-03-02
May, 2015 FDA 483 Response Abrams Royal Pharmacy II, LLC - Form 483R, 2015-05-11
July, 2017 FDA 483 Drug Crafters - Form 483, 2017-07-11
April, 2019 FDA 483 ZENARA PHARMA PRIVATE LIMITED - Form 483, 2019-04-26
October, 2018 EIR Avance Biosciences Inc - EIR, 2018-10-04
February, 2020 FDA 483 AARTI PHARMALABS LIMITED - Form 483, 2020-02-20
November, 2014 FDA 483 Option Care - Form 483, 2014-11-25
September, 2019 FDA 483 Innoveix Pharmaceuticals Inc - Form 483, 2019-09-12
September, 2015 FDA 483 PharMedium Services, Llc - Form 483, 2015-09-24
July, 2018 FDA 483 Drug Crafters - Form 483, 2018-07-11
October, 2019 FDA 483 Sawai Pharmaceutical Co., Ltd. - Form 483, 2019-10-15
December, 2017 FDA 483 PharMedium Services, Llc - Form 483, 2017-12-22
March, 2018 FDA 483 Tomita Pharmaceutical Co., Ltd. - Form 483, 2018-03-09
November, 2014 FDA 483 Response Option Care - Form 483R, 2014-12-15
February, 2020 FDA 483 RECIPHARM PHARMASERVICES PRIVATE LIMITED - Form 483, 2020-02-13
November, 2018 FDA 483 The University of Texas Southwestern Medical Center - Form 483, 2018-11-09
June, 2014 FDA 483 Medical Supply Liquidators Llc - Form 483, 2014-06-19
June, 2015 EIR Brio Pharmaceuticals, Inc - EIR, 2015-06-01
April, 2015 FDA 483 Custom Compounding Center - Form 483, 2015-04-09
December, 2018 FDA 483 RECIPHARM PHARMASERVICES PRIVATE LIMITED - Form 483, 2018-12-07
March, 2017 FDA 483 Village Compounding Pharmacy - Form 483, 2017-03-31
August, 2016 FDA 483 DPT Laboratories, Ltd. - Form 483, 2016-08-26
September, 2016 EIR DSM Nutritional Products France SAS - EIR, 2016-09-16
January, 2017 FDA 483 South Texas Botanicals - Form 483, 2017-01-12
January, 2018 FDA 483 Empower Clinic Services LLC dba Empower Pharmacy - Form 483, 2018-01-24
March, 2019 FDA 483 Exela Pharma Sciences, LLC. - Form 483, 2019-03-29
June, 2014 EIR Shonka, Dr Nicole - EIR, 2014-06-20
February, 2020 EIR AARTI PHARMALABS LIMITED - EIR, 2020-02-20
November, 2016 EIR DPT Laboratories, Ltd. - EIR, 2016-11-09
August, 2017 FDA 483 Lincare, Inc. - Form 483, 2017-08-22
June, 2017 FDA 483 QuVa Pharma, Inc. - Form 483, 2017-06-02
March, 2017 EIR American Specialty Pharmacy - EIR, 2017-03-02

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more